[go: up one dir, main page]

IN2014DN05759A - - Google Patents

Info

Publication number
IN2014DN05759A
IN2014DN05759A IN5759DEN2014A IN2014DN05759A IN 2014DN05759 A IN2014DN05759 A IN 2014DN05759A IN 5759DEN2014 A IN5759DEN2014 A IN 5759DEN2014A IN 2014DN05759 A IN2014DN05759 A IN 2014DN05759A
Authority
IN
India
Prior art keywords
control
basification
hcv
viral
formation
Prior art date
Application number
Other languages
English (en)
Inventor
Mathias Braun
Carl Alan Busacca
feng jing Chen
Edwin Louis Gump
Jenness B Majeska
Scott Pennino
Fenghe Qiu
Maria Fernanda Villagra
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47628447&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN05759(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IN2014DN05759A publication Critical patent/IN2014DN05759A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN5759DEN2014 2012-01-12 2013-01-10 IN2014DN05759A (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261586087P 2012-01-12 2012-01-12
PCT/US2013/020934 WO2013106506A1 (en) 2012-01-12 2013-01-10 Stabilized pharmaceutical formulations of a potent hcv inhibitor

Publications (1)

Publication Number Publication Date
IN2014DN05759A true IN2014DN05759A (no) 2015-04-10

Family

ID=47628447

Family Applications (1)

Application Number Title Priority Date Filing Date
IN5759DEN2014 IN2014DN05759A (no) 2012-01-12 2013-01-10

Country Status (27)

Country Link
US (2) US20140037719A1 (no)
EP (1) EP2802313A1 (no)
JP (1) JP2015503616A (no)
KR (1) KR20140109433A (no)
CN (1) CN104244926A (no)
AP (1) AP2014007760A0 (no)
AR (1) AR089710A1 (no)
AU (1) AU2013208024A1 (no)
BR (1) BR112014017058A8 (no)
CA (1) CA2861041A1 (no)
CL (1) CL2014001783A1 (no)
CO (1) CO7000774A2 (no)
EA (1) EA201400808A1 (no)
EC (1) ECSP14013104A (no)
HK (1) HK1204982A1 (no)
IL (1) IL233550A0 (no)
IN (1) IN2014DN05759A (no)
MA (1) MA35865B1 (no)
MX (1) MX2014008205A (no)
NZ (1) NZ626353A (no)
PE (1) PE20141817A1 (no)
PH (1) PH12014501598A1 (no)
SG (1) SG11201404042VA (no)
TN (1) TN2014000295A1 (no)
TW (1) TW201340969A (no)
UY (1) UY34569A (no)
WO (1) WO2013106506A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA119315C2 (uk) 2012-07-03 2019-06-10 Гіліад Фармассет Елелсі Інгібітори вірусу гепатиту с
WO2014145095A1 (en) 2013-03-15 2014-09-18 Gilead Sciences, Inc. Macrocyclic and bicyclic inhibitors of hepatitis c virus

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5329976A (en) * 1991-12-09 1994-07-19 Habley Medical Technology Corporation Syringe-filling and medication mixing dispenser
US6323180B1 (en) 1998-08-10 2001-11-27 Boehringer Ingelheim (Canada) Ltd Hepatitis C inhibitor tri-peptides
UY28240A1 (es) * 2003-03-27 2004-11-08 Boehringer Ingelheim Pharma Fases cristalinas de un potente inhibidor de la hcv
EP1654261B1 (en) 2003-05-21 2007-11-14 Boehringer Ingelheim International GmbH Hepatitis c inhibitor compounds
US7514557B2 (en) 2004-05-25 2009-04-07 Boehringer Ingelheim International Gmbh Process for preparing acyclic HCV protease inhibitors
WO2006130552A2 (en) * 2005-06-02 2006-12-07 Schering Corporation Methods of treating hepatitis c virus
MY153093A (en) 2008-09-16 2014-12-31 Boehringer Ingelheim Int Crystalline forms of a 2-thiazolyl-4-quinolinyl-oxy derivative, a potent hcv inhibitor
UA105777C2 (uk) * 2008-11-21 2014-06-25 Бьорінгер Інгельхайм Інтернаціональ Гмбх Фармацевтична композиція ефективного інгібітора вгс для перорального введення
KR101685941B1 (ko) 2009-07-07 2016-12-13 베링거 인겔하임 인터내셔날 게엠베하 Ｃ형 간염 바이러스 프로테아제 억제제를 위한 약제학적 조성물

Also Published As

Publication number Publication date
PH12014501598A1 (en) 2014-10-08
BR112014017058A2 (pt) 2017-06-13
BR112014017058A8 (pt) 2017-07-04
CN104244926A (zh) 2014-12-24
US20140037719A1 (en) 2014-02-06
JP2015503616A (ja) 2015-02-02
AU2013208024A1 (en) 2014-07-10
US20150190458A1 (en) 2015-07-09
CO7000774A2 (es) 2014-07-21
EP2802313A1 (en) 2014-11-19
AP2014007760A0 (en) 2014-07-31
UY34569A (es) 2013-07-31
AR089710A1 (es) 2014-09-10
KR20140109433A (ko) 2014-09-15
CA2861041A1 (en) 2013-07-18
SG11201404042VA (en) 2014-08-28
MX2014008205A (es) 2014-08-08
NZ626353A (en) 2016-02-26
CL2014001783A1 (es) 2014-12-12
EA201400808A1 (ru) 2015-02-27
TW201340969A (zh) 2013-10-16
PE20141817A1 (es) 2014-12-17
HK1204982A1 (en) 2015-12-11
ECSP14013104A (es) 2015-11-30
MA35865B1 (fr) 2014-12-01
TN2014000295A1 (en) 2015-12-21
IL233550A0 (en) 2014-08-31
WO2013106506A1 (en) 2013-07-18

Similar Documents

Publication Publication Date Title
MX354516B (es) Vectores que codifican el factor de viabilidad de conos derivado de bastones.
PL3224254T3 (pl) Podstawione indazole, sposób ich wytwarzania, preparaty farmaceutyczne je zawierające, oraz ich zastosowanie do wytwarzania leków
WO2012040389A3 (en) Substituted bicyclic hcv inhibitors
PT2890683T (pt) Derivados de sulfamoílo bicíclicos fundidos e a sua utilização como medicamentos para o tratamento da hepatite b
ZA201600415B (en) Novel derivatives of indole and pyrrole, method for the production thereof and pharmaceutical compositions containing same
NZ721780A (en) Heterocyclic modulators of lipid synthesis for use against cancer and viral infections
IL236581A0 (en) History of astra-5,3,1 (10), 16-tetrane modified in position 3, methods for their production, pharmaceutical preparations containing them, and their use for the production of drugs
EP3244900A4 (en) Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same
ZA201806357B (en) Protein based excipient for active pharmaceutical ingredients
MD20150053A2 (ro) Produs de comicronizare cu conţinut de acetat de ulipristal
IN2014DN05759A (no)
MX358507B (es) Antigenos vacunales quimericos contra el virus de la hepatitis c.
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
IL253824A0 (en) Pharmaceutical formulations of c1 esterase inhibitor
SG11201610453SA (en) Compounds for inhibiting hepatitis c virus, pharmaceutical compositions and uses thereof
WO2014159501A3 (en) Processes for preparing tetrahydroisoquinolines
EP3065737A4 (en) Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form
ZA201901004B (en) High drug loaded tablet composition for treating hiv
IN2014MU00077A (no)
HUP1400084A2 (hu) Dabigatran és származékainak komplexei, elõállítása és gyógyszerészeti kompozíciói
HUP1300648A2 (hu) Dabigatran és származékainak komplexei,elõállításuk és gyógyszerészeti kompozícióik
IN2014MU00076A (no)
MY185444A (en) Enterovirus 71 antiviral peptides
MX2015003954A (es) Composicion farmaceutica de liberacion controlada en tres pulsos dependientes de ph de betahistina.
TH1301000018B (th) รูปผลึกเดลตาของเกลืออาร์จินีน (arginine) ของเพอรินโดพริล (perindopril), กระบวนการสำหรับการเตรียมสารดังกล่าว และองค์ประกอบทางเภสัชกรรมที่มีสารดังกล่าว